(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(3-methoxyphenyl)prop-2-enenitrile

Catalog No. :
ACHDUK924
CAS No. :
478248-61-2
Molecular Formula :
C24H18ClN3O
Molecular Weight :
399.88

IUPAC Name:(Z)-3-(2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)-2-(3-methoxyphenyl)acrylonitrile

(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(3-methoxyphenyl)prop-2-enenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$281.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(3-methoxyphenyl)prop-2-enenitrile
IUPAC Name(Z)-3-(2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)-2-(3-methoxyphenyl)acrylonitrile
Molecular FormulaC24H18ClN3O
Molecular Weight399.88
SMILESN#C/C(C1=CC=CC(OC)=C1)=C\C2=C(C3=CC=C(Cl)C=C3)N=C4C=C(C)C=CN42
InChI KeyJWJZXRPLUYXQKR-XMHGGMMESA-N
Synonym(Z)-3-[2-(4-CHLOROPHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL]-2-(3-METHOXYPHENYL)-2-PROPENENITRILE;(2Z)-3-[2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(3-methoxyphenyl)prop-2-enenitrile;Benzeneacetonitrile, α-[[2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]methylene]-3-methoxy-
CAS No.478248-61-2

Synthetic Route by SureRoute

1. ACHDUK924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDUK924 route product structure diagram
    ACHDUK924478248-61-2
Inquiry

2. ACHDUK924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDUK924 route product structure diagram
    ACHDUK924478248-61-2
Inquiry

Comments (0)